Status:
COMPLETED
Evaluation of Safety and Efficacy of Remifentanil in Pediatric Population
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Ajou University School of Medicine
Severance Hospital
Conditions:
Infant, Preterm
Eligibility:
All Genders
Up to 12 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to evaluate safety and efficacy of continuous infusion of remifentanil in preterm infant with mechanical ventilator for control of procedural pain using two different dosa...
Eligibility Criteria
Inclusion
- preterm infants mechanically ventilated
- requiring peripherally induced central catheterization
- with informed consent of their parents
Exclusion
- major congenital anomalies
- cardiopulmonary instability
- use of sedative, antiepileptic drugs or anesthetic drugs
- grade III or IV intraventricular hemorrhage
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT01477892
Start Date
December 1 2011
End Date
April 1 2012
Last Update
September 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Children's Hospital
Seoul, South Korea